All In MedTech

Device Trial Radar · NCT06997549

Retrospective Analyses of the Greenbrook Database Evaluating Mental Health Treatments

Last checked: Nov 19, 2026Latest source record: Apr 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

12,000

Planned (sponsor's estimate)

Start

May 15, 2025

Primary completion

Dec 2035

Study completion Dec 2035

Sponsor

Lead sponsor
NeuroneticsAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
May 30, 2025

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 5 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study involves multiple retrospective analyses to understand the utilization of mental health treatments provided at Greenbrook and their effectiveness

Conditions

  • Depression
  • OCD
  • Anxiety Depression

Interventions

  • Patients treated with NeuroStar TMSDevice

    non-invasive brain stimulation device

  • Patients treated with EsketamineDrug

    nasal spray for treating depression

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. change in clinical outcome scores from baseline to post treatmentTime frame: 8 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Neuronetics

    Malvern, Pennsylvania · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.